Small study ties rarely reported condition to pediatric pain | Brain's endocannabinoids help reduce pain when fear strikes | Drug curbs chest pain in diabetes patients
Web Version
March 13, 2013
News for the pain professional

Pain Research News
Small study ties rarely reported condition to pediatric pain
U.S. researchers assessed 41 patients with unexplained widespread pain that started before age 21 and found that 24 of them met the diagnosis criteria for small-fiber polyneuropathy, while 16 of the remaining 17 were considered to possibly or probably have SFPN. The report in Pediatrics also found that 82% of patients had reduced sweat production, considered a sensitive diagnostic test for SFPN. American News Report (3/11)
Share: LinkedIn Twitter Facebook Google+ Email
Brain's endocannabinoids help reduce pain when fear strikes
Interactions among marijuana-like substances and other neurotransmitters in the brain's amygdala region can suppress pain in times of extreme stress, a study in the journal Pain found. "This research provides information on the complex interactions between multiple neurotransmitter systems including endocannabinoids, GABA and glutamate in times of stress and pain," National University of Ireland researcher David Finn said. Galway Independent (Ireland) (3/7)
Share: LinkedIn Twitter Facebook Google+ Email
Treatment News
Drug curbs chest pain in diabetes patients
Data on 927 diabetes patients showed those who took Gilead Sciences' angina drug Ranexa had 3.8 episodes of chest pain per week, while those who received a placebo experienced 4.3 per week. Ranexa-treated patients also required less nitroglycerin, researchers reported at the American College of Cardiology meeting. Reuters (3/10)
Share: LinkedIn Twitter Facebook Google+ Email
NSAIDs are safe choice after tonsillectomy, study says
Nonsteroidal anti-inflammatory drugs are a safe method of pain relief for children following tonsillectomy, offering no increased risk of severe bleeding, McMaster University researchers reported in Clinical Otolaryngology. Their review of study data compared NSAIDs with opioids and placebo and found no increased risk for the most severe outcomes after tonsillectomy. MedWire News (U.K.) (3/12)
Share: LinkedIn Twitter Facebook Google+ Email
Other News
Policy & Trends
48 states ask FDA for more oversight of generic drugmakers
Attorneys general in 48 states asked the FDA to increase oversight of generic drug manufacturers to prevent the abuse of medications, including painkillers. North Carolina Attorney General Roy Cooper said greater adoption of tamper-resistant features is needed. American City Business Journals/Greater Traid Area (3/11)
Share: LinkedIn Twitter Facebook Google+ Email
Researchers urge review of narcotics for osteoarthritis pain
Researchers from the Albert Einstein College of Medicine called for a review of the use of narcotic medications for patients with osteoarthritis. Their report in the Journal of the American Geriatrics Society found prescriptions for NSAIDs declined among a study population with osteoarthritis while prescriptions for narcotic medications increased from 2001 to 2004, followed by an increase in falls and fractures. MedWire News (U.K.) (3/12)
Share: LinkedIn Twitter Facebook Google+ Email
Other News
APS News
Data Blitz deadline extended to March 25
Do you have an innovative and compelling clinical or basic science research abstract? Submit your work to APS for the Clinical and Basic Science Data Blitz, to be held May 8 in New Orleans as part of the 32nd Annual Scientific Meeting. Selected presenters will be notified in early April and will have five minutes to present their research data. Authors are encouraged to submit innovative and compelling clinical and basic science research for presentation. Submissions from doctoral students and postdoctoral fellows are encouraged. Learn more.
Share: LinkedIn Twitter Facebook Google+ Email
Annual Scientific Meeting: Early-bird deadline 2 weeks away
At the APS's 32nd Annual Scientific Meeting in New Orleans, May 8-11, you can expect a variety of educational offerings featuring interactive workshops and symposia, allowing you to earn continuing education credit in four disciplines. Three plenary lectures include topics on pain imaging, pain and aging, and mechanisms for controlling nociceptor. If you specialize in complementary and alternative medicine, register for the newly announced preconference event, Complementary and Alternative Medicine: Roles in Chronic Pain Management & Research, on May 8. Learn more. There are only two weeks before the registration fee increases. Register by March 27 to save $100.
Share: LinkedIn Twitter Facebook Google+ Email
Humor is an affirmation of dignity, a declaration of man's superiority to all that befalls him."
-- Romain Gary,
French diplomat, novelist, film director and aviator
Share: LinkedIn Twitter Facebook Google+ Email
Learn more about APS ->About APS | Membership | Education | Resources | Journal of Pain
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Lead Editor:  Tom Parks
Advertising:  Aaron Kern
  P: 202.407.7866

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.®
Privacy policy |  Legal Information